[CBAY] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[CBAY] CymaBay Therapeutics, Inc.
Announcement Date
10-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 97.70%
YoY- 97.34%
Quarter Report
CBAY's Result
CBAY's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 31,016 0 0 0 0 0 0 -
PBT -808 -27,094 -23,222 -10,726 -24,038 -17,531 -8,929 -32.98%
Tax 5,900 3,325 0 -614 1,610 42 -781 -
NP -808 -30,419 -23,222 -10,726 -24,038 -17,531 -8,929 -32.98%
Tax Rate - - - - - - - -
Total Cost 31,824 30,419 23,222 10,726 24,038 17,531 8,929 23.58%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin -2.61 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS -0.01 -0.36 -0.34 -0.16 -0.35 -0.30 -0.31 -43.56%
EPS Diluted -0.01 -0.35 -0.34 -0.16 -0.35 -0.30 -0.31 -43.56%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.